NMR characterizations indicate the binding site of B4-27 is mainly overlapped with SI/II-P.297,298 With continuous improvement in chemical compositions, cellular permeability, and metabolic stability, B4-27 displays good potency in blocking Ras-effector interactions and induces apoptosis of multiple cancer cell lines containing KRAS or HRAS mutants. Here, KRAS is linked to cancer.